RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
78 hedge funds and large institutions have $546M invested in Revance Therapeutics, Inc. in 2017 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 23 increasing their positions, 28 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
78
Holders Change
-3
Holders Change %
-3.7%
% of All Funds
1.94%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
23
Reduced
28
Closed
9
Calls
$687K
Puts
$349K
Net Calls
+$338K
Net Calls Change
-$26K
Top Buyers
| 1 |
1
BlackRock
New York
|
$42.6M |
| 2 |
2
Fidelity Investments
Boston,
Massachusetts
|
$6.59M |
| 3 |
3
Goldman Sachs
New York
|
$11.4M |
| 4 |
4
State Street
Boston,
Massachusetts
|
$9.36M |
| 5 |
PC
5
PointState Capital
New York
|
$5.75M |
